تيرازوسين تيڤع ٥ ملغ

main_info

  • trade_name:
  • تيرازوسين تيڤع ٥ ملغ
  • pharmaceutical_form:
  • TABLETS
  • administration_route:
  • PER OS
  • medicine_domain:
  • Human
  • medicine_type:
  • Allopathic
  • manufactured_by:
  • TEVA PHARMACEUTICAL INDUSTRIES LTD

documents

localization

  • country:
  • تيرازوسين تيڤع ٥ ملغ
    إسرائيل
  • language:
  • العربية

therapeutic_information

  • therapeutic_group:
  • TERAZOSIN
  • therapeutic_indication:
  • For symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (BPH). For mild to moderate hypertension.

status

  • source:
  • Ministry of Health - State of Israel
  • authorization_number:
  • 138823145700
  • authorization_date:
  • 01-06-2013
  • last_update:
  • 09-08-2016

doc_PIL: head_title_medicine_info

TerazosinHCldihydrate1mg TerazosinHCldihydrate2mg

"

TerazosinHCldihydrate5mg

" ! #

&

"

(BPH) % !

& '

" !

"

## '

& ' )

"

## ( # ## ( # # (

## ) %

& " '

& '

& '

& '

&

)$ # '

&

& ( !'

" % ! " - !

" "

" ! #" #

" "

$ ## # (

# !

# $

" # " !

&

## $ ) '

" %

"

%"

& " '

"

$# ) ,,,, '

& '

$# $# - ) ,,,, '

"

" %

#)# &

(exp.date) ! #

" ! "

Lactosemonohydrate,starch,crospovidone,talc,povidone,magnesiumstearate,alcohol95%,

colorquinolineyellow(E104)aluminiumlake18-24%(presentonlyinthe2mg),ironoxidered

andyellow(presentonlyinthe5mg).

!. !

" ( ./ " ( 0, " !

" ./ " ( 0 " !

" ./ " ( 0 " !

" ! ! /., (

/$!$/!/+$!,,

/$!$+!/+.!,,

/$!$!/+0!,,